Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025)

SOPHiA GENETICS's Total Debt history spans 3 years, with the latest figure at $47.7 million for Q4 2025.

On a quarterly basis, Total Debt rose 260.6% to $47.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.7 million, a 260.6% increase, with the full-year FY2025 number at $47.7 million, up 260.6% from a year prior.
Total Debt hit $47.7 million in Q4 2025 for SOPHiA GENETICS, up from $13.2 million in the prior quarter.
Over the last five years, Total Debt for SOPH hit a ceiling of $47.7 million in Q4 2025 and a floor of $13.2 million in Q4 2024.